Featured Research

from universities, journals, and other organizations

Heart health: Implanted devices as effective in 'real world' as in clinical trial settings

Date:
November 23, 2010
Source:
American Heart Association
Summary:
Survival rates for patients with implanted defibrillators and resynchronization devices in the general population are similarly high as rates in clinical trial settings. Remote monitoring of the devices over a network is linked to improved survival odds.

Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a large new study reported in Circulation: Journal of the American Heart Association.

In the study, researchers focused on three devices:

  • Implantable cardioverter defibrillator (ICD) -- shocks the heart to treat dangerously fast rhythms in its lower chambers, or ventricles, and can also treat sudden cardiac arrest;
  • Cardiac resynchronization therapy (CRT) -- coordinates pumping of the two ventricles and improves heart efficiency in heart failure patients;
  • CRT-D -- a defibrillator with a CRT device.

Researchers examined data on 185,778 ICD and CRT patients (average age 67). After one year, 92 percent of ICD recipients and 88 percent of CRT-D patients were alive. Survival rates after five years were 68 percent for ICD and 54 percent for CRT-D. Among 8,228 CRT-only patients, the survival rate was 82 percent at one year and 48 percent at five years.

"I'm very encouraged that survival after defibrillator implant is as good as it is for as long as it is," said Leslie A. Saxon, M.D., co-author of the study.

The data complement previous results of clinical trials that evaluated ICDs for primary prevention of sudden death. Real world patients were expected to fare worse because they could also be using an ICD for secondary prevention (recurrent event), which puts them at higher risk.

The study also found that patients whose devices were subject to ongoing remote monitoring on a network were about half as likely to have died as were those receiving traditional in-clinic monitoring only, which typically occurs quarterly.

"There's a lot of good news here," said Saxon, chief of the division of cardiovascular medicine at the University of Southern California's Keck School of Medicine in Los Angeles. "We need to expand the capabilities of these networks; they are very promising for our patients." Cardiologists decide whether to enroll patients in a remote monitoring network, which is available only for ICD and CRT-D devices and is free. Enrolled patients are mailed a communicator unit that connects to their telephone line and queries the implant daily about how it's functioning and whether cardiac events occurred. That data is delivered to a website the physician monitors.

The communicator can also help monitor other health indicators, dispatching data on factors such as fatigue, weight or blood pressure.

Changes in weight and blood pressure can predict worsening status. Patients with CRT-Ds whose communicators regularly transmitted weight and blood pressure data had a lower risk of death than did other networked CRT-D patients.

Because the network gives a continuous view of patients' status -- and provides alerts when something is wrong -- physicians can more effectively triage their patients and intervene immediately.

"It's highly likely the reason these patients did better is that they were receiving earlier diagnoses, and they were also empowered to take charge of their own health care more," Saxon said. "I don't think there's any reason not to put a patient on it."

The new study is part of ongoing research called the ALTITUDE project, involving physicians from across the United States who are learning how to optimize ICD, CRT and CRT-D devices.

"We're trying to use data from tens of thousands of patients to better individualize therapy and get the best outcomes out of it," Saxon said. "It's a new frontier of managing sick patients."

Patients who received a CRT-only device, and who as a group fared worse than the others, were older, with an average age of 76.

Selection bias may help explain their lower survival rates, Saxon said. The patients received the CRT-only devices because they tended to be sicker and doctors focused on resynchronization to support the heart, with less attention to the possibility of arrhythmias.

"Maybe those patients died more because they didn't have a defibrillator and they succumbed to a malignant arrhythmia," she said.

Most patients given implantable heart devices in the last five years have received the defibrillator part of the device to prevent death from sudden cardiac arrest, Saxon said.

"Without defibrillators, 98 percent of patients (with a malignant arrhythmia) die because they require a shock right away," she said.

The implants can deliver that shock within about 15 seconds.

Co-authors are: David L. Hayes, M.D.; F. Roosevelt Gilliam, M.D.; Paul A. Heidenreich, M.D.; John Day, M.D.; Milan Seth, M.S.; Timothy E. Meyer, Ph.D.; Paul W. Jones, M.S.; and John P. Boehmer, M.D. Author disclosures and sources of funding are on the manuscript.

Boston Scientific, a manufacturer of the devices, funded the research.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Leslie A. Saxon, David L. Hayes, F. Roosevelt Gilliam, Paul A. Heidenreich, John Day, Milan Seth, Timothy E. Meyer, Paul W. Jones, and John P. Boehmer. Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study. Circulation, November 22, 2010 DOI: 10.1161/CIRCULATIONAHA.110.960633

Cite This Page:

American Heart Association. "Heart health: Implanted devices as effective in 'real world' as in clinical trial settings." ScienceDaily. ScienceDaily, 23 November 2010. <www.sciencedaily.com/releases/2010/11/101122172133.htm>.
American Heart Association. (2010, November 23). Heart health: Implanted devices as effective in 'real world' as in clinical trial settings. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/11/101122172133.htm
American Heart Association. "Heart health: Implanted devices as effective in 'real world' as in clinical trial settings." ScienceDaily. www.sciencedaily.com/releases/2010/11/101122172133.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins